VAM
ELV icon

Veritas Asset Management’s Elevance Health ELV Stock Holding History

Veritas Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166M Sell
428,672
-206,699
-33% -$76.7M 2.98% 16
2026
Q1 		$186M Sell
635,371
-238,622
-27% -$78.4M 3.15% 14
2025
Q4 		$306M Sell
873,993
-28,907
-3% -$9.77M 3.14% 14
2025
Q3 		$292M Sell
902,900
-10,458
-1% -$3.25M 3.12% 13
2025
Q2 		$355M Sell
913,358
-39,545
-4% -$15.9M 3.55% 13
2025
Q1 		$414M Sell
952,903
-33,835
-3% -$13.6M 4.19% 12
2024
Q4 		$364M Sell
986,738
-111,040
-10% -$46.5M 3.39% 14
2024
Q3 		$571M Sell
1,097,778
-39,284
-3% -$21M 4.22% 12
2024
Q2 		$616M Sell
1,137,062
-22,917
-2% -$12.1M 4.66% 12
2024
Q1 		$601M Sell
1,159,979
-11,946
-1% -$5.94M 4.36% 11
2023
Q4 		$553M Sell
1,171,925
-29,864
-2% -$13.8M 3.98% 13
2023
Q3 		$523M Buy
1,201,789
+68,778
+6% +$31.2M 3.94% 12
2023
Q2 		$503M Buy
+1,133,011
New +$523M 3.5% 14

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Veritas Asset Management's ELV Position: Q2 2026 in Review

Veritas Asset Management reduced its Elevance Health (ELV) stake by 33% in Q2 2026, selling an estimated $76.7M and leaving 428,672 shares worth $166M. The position accounts for 2.98% of the portfolio, ranked #16.

Veritas Asset Management first reported a position in ELV in Q2 2023 and has held it in 13 quarters since. The position peaked at $616M in Q2 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Veritas Asset Management held 428,672 shares of Elevance Health worth $166M as of Q2 2026.
  • Veritas Asset Management sold 206,699 Elevance Health shares in Q2 2026, an estimated $76.7M.
  • Elevance Health made up 2.98% of Veritas Asset Management's portfolio in Q2 2026, its #16 holding.
  • Veritas Asset Management first reported a position in Elevance Health in Q2 2023 and has held it in 13 quarters since.
  • Veritas Asset Management's Elevance Health position peaked at $616M in Q2 2024.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Veritas Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.